Condition: Heart Transplantation · Sponsor: Heinrich-Heine University, Duesseldorf
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
This description comes directly from the study's public registry record.
Amin Polzin, Prof. · 0211 81 18801 · amin.polzin@med.uni-duesseldorf.de
Fabian Voß, Dr. med. · 02118118800 · fabian.voss@med.uni-duesseldorf.de
Always discuss trial participation with your own doctor first.
| University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07372820